[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"miscarriage-with-afibrinogenemia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:miscarriage-with-afibrinogenemia":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100466933","new-cross-linked-hyaluronan-gel-to-prevent-adhesion-after-usg-mva-rct-100466933",false,"NCT05360186","New Cross-linked Hyaluronan Gel to Prevent Adhesion After USG-MVA: RCT","The Efficacy and Safety of a New Cross-linked Hyaluronan Gel to Prevent Adhesion After Ultrasound-guided Manual Vacuum Aspiration (USG-MVA): A Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Women 18 years old or above\n* No previous history of IUA\u002F Asherman's syndrome\n* No previous surgical history of EVA or dilatation or curettage or surgical termination of pregnancy or caesarean section\n* No previous history of therapeutic hysteroscopic surgeries\n* Voluntary informed consent and understanding of study\n\nExclusion Criteria:\n\n* previous therapeutic hysteroscopic procedures (e.g. endometrial ablation, removal of fibroids or polyps, surgical correction of congenital uterine anomalies or adhesiolysis)\n* suspicion of molar pregnancy\n* genital tract malformation\n* suspicion of active infection or genital tract malignancy or genital tuberculosis\n* abnormal blood coagulation\n* inability to tolerate pelvic examination known\n* suspected intolerance of hypersensitivity to NCH gel or its derivatives\n* patient refusal","FEMALE","18 Years","50 Years",{"count":20,"type":21},150,"ESTIMATED","INTERVENTIONAL",[24],"NA","The objective of this prospective, randomized controlled study was to evaluate the effectiveness of this NCH gel in the prevention of IUA development as assessed by hysteroscopy after USG-MVA, in the treatment for first-trimester miscarriage.\n\n* To study the severity and extent of the IUA as assessed by the AFS and ESGE adhesion score in both groups of patients.\n* To examine the rate of complications or side effects with the NCH gel.\n* To assess the subsequent menstrual history and reproductive outcome in both groups of patients.",[27,28,29],"First Trimester Abortion","Surgical Abortion","Miscarriage With Afibrinogenemia",[27,28,31,32,33,34,35,36],"Intrauterine adhesion","Hyaluronan gel","Protective Agents","Hyaluronic Acid","Manual vacuum aspiration","Miscarriage","RECRUITING","2025-08-12",{"date":40,"type":41},"2025-08-13","ACTUAL",{"date":43,"type":41},"2022-06-14",{"date":45,"type":21},"2026-05-15",{"name":47,"class":48},"Chinese University of Hong Kong","OTHER"]